`
`DJJF MMMHE?AJH=??LAJHO?KHEAHAMI?=AMI?LAJHOFE?AIMEJ?DJAIJAF
`=H?=@HALAHI=EJ=HJE?A%%"? #" A$'A%?B% $>&"#?=?DJ
`
`+LAJHOFE?AIMEJ?DJAIJAF=H?=,HALAHI=
`EJ
`
`*O-,4)-1/01-4 K! $
`
`+8-64;ߞ6DAHAߣI=AMBHB=H?==L=E=>AE==I=IFH=O=@IB=HJDA
`
`+LAJHO2E?A,AF=HJAJEIJDABEHIJEJDAIJ=JAJKIAEJ=??H@ECJ+LAJHO
`
`2E?A,AF=HJAJ+=FJ=E2AJAH==>MIE
`
`6DA,AF=HJAJM=IANFA?JECJDAEHBEHIJIDEFAJBJDEIAM=I=BH@=OH
`
`6KAI@=O==>MIEI=E@JDABHJDAOD=LA>AAKIECEIJDAEA?JEMDE?D?AI
`
`E=BAMF=HJI=@J=AI=>KJIA?@IJFKJJCAJDAHEH@AHJEA?JEJ
`
`É;KCJ=I?AA=@EJJ=AIJEA=@ALAEBOKD=LAANFAHEA?A=@EEIJAHEC
`
`JDAEA?JE=EA?JEEIJAHHHFB=@OKD=LAA>AHIBJDAB=EOH
`
`JDAHI=HK@OKMD=HA=KFIAJ=@FIIE>OOAEC=@?HOECMDEAOKߣHAJHOEC
`
`J@JDEIÉDAI=E@
`
`+LAJHO2E?AD=LA>AA?=HHOECJDAEA?JEBH=>KJJMOA=HI=@=CMEJD
`
`JDAJEAEJJ=AIJ=@EEIJAHDAI=E@JDAC=IILE=EILAHOBH=CEA6DAEA?JEBH
`
`D@IJMEECH=IBJDA@HKCMDEAJDAAM=I=LAHIED@IBKH
`
`É;KJ=AEJKJBJDAF=?=CA=@KIAEJ@AÉI=E@JDA+=FJ=EÉ0MK?DFEE@
`
`JDAFAHID=I?IKA@@AJAHEAIEBJDAOHAGKEHA=IA?@@IA>KJJD=JFAHI
`
`MEIJE>AJH=IFHJA@JJDADIFEJ=É
`
`)??H@ECJDEIEBH=JEE #JDA,AF=HJAJKIA@EJAECDJJEAI5B=HJDEI
`
`OA=HEJߣI>AAKIA@JME?A
`
`DJJF MMMHE?AJH=??LAJHO?KHEAHAMI?=AMI?LAJHOFE?AIMEJ?DJ
`
`Opiant Exhibit 2160
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 1
`
`
`
`+LAJHOFE?AIMEJ?DJAIJAF=H?=,HALAHI=EJ?=AMIHE?AJH=?
`
`É9DALAHCAJIJJDAI?AAB=IJAHFE?AHBEHAME@EIFAIAEJÉDAI=E@É6DA
`
`EA?JE?IJI%=FEA?AMDEAJDA=I=IFH=OEIJMBH%#=@JDA=I=IFH=OEI=
`
`JI=BAHBHAAHCA?OFAHIA=@EJCAJIEJJDA>@OߣIIOIJAHECDJ=M=OÉ
`
`0AANF=EA@JD=JFEE@@HKCIE?K@AHFDEA?@AEAAJD=@ANO?@A
`
`=@EJIL=HEKIBHI=IMA=IEAC=@HKCIIK?D=IDAHE0AI=E@IABJDA
`
`IOFJIB=LAH@IAE?K@A==?BHAIFIAJK@LE?AIH ID=EC
`
`BECAH=EI=@EFIJKHEC>KAHFKHFA >HA=JDECEIIMID=MHEHHACK=HH
`
`D=IIJFFA@ ANJHAAOI=FKFEI=@IMDA=HJ>A=J=@HM>@FHAIIKHA
`
`É)OA?=IKBBAHBH=LAH@IAÉDAI=E@ÉEJ?K@>A=A@AHOFAHIMD
`
`BHCJJDAOJJDAEHA@E?=JE=HA=@O=@JDAOJ=AEJ=C=EHEJ?K@>A=?DE@
`
`MDCAJIEJJDAA@E?EA?=>EAJÉ
`
`0AI=E@E #JDAHAMAHA #&@A=JDIE4D@A1I=@BHLAH@IAIKFBH !'
`
`E "5B=HJDEIOA=HEJߣI"@A=JDI)??H@ECJ5OLE=*KHMAIA?HAJ=HOBJDA
`
`75,AF=HJAJB0A=JD=@0K=5AHLE?AIJDAFEE@AFE@AE?MI
`
`>K@=HEAI
`
`É1JJK?DAIELAIE?EJEAIHKH=?KJEAI=@IK>KH>=AECD>HD@I=?HIIJDA
`
`?KJHOÉIDAI=E@É6D=JߣIMDOEJߣIIEFHJ=JJD=JMA?AJCAJDAHߞ>JDIJ=JA
`
`=@BA@AH=A=@AHIߞ=@J=A=?H@E=JA@=@?FHADAIELA=FFH=?DJ
`
`=@@HAIIJDEI?HEIEIÉ
`
`+LAJHO2E?A,AF=HJAJ+DEAB+AD=?,=@IJHAIIAI=HAE@AH=>KJ
`
`JDA/@5==HEJ=LAH@IA2HALAJE)?JB $
`
`É,JDAIEJ=JAJ?='EBOKD=LA=BHEA@HB=EOA>AHMDOK>AEALAEI
`
`LAH@IEC6DAHAFHJECF=HJO=@JDAF=JEAJ=HA=BBH@A@EKEJOBH
`
`FHIA?KJEK@AHJDEI=MMDAJDAO=HAIAAECA@E?=JHA=JAJBHE@ELE@K=I
`
`IKBBAHEC=@HKCLAH@IA5=LECELAIEIJDAK>AHAFHEHEJO=IMA>=JJAJDEI
`
`FK>E?DA=JD?HEIEIMDE?D?JEKAIEJI=II=KJKH?KEJEAIÉDAI=E@
`
`DJJF MMMHE?AJH=??LAJHO?KHEAHAMI?=AMI?LAJHOFE?AIMEJ?DJ
`
`Opiant Exhibit 2160
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 2
`
`
`
`+LAJHOFE?AIMEJ?DJAIJAF=H?=,HALAHI=EJ?=AMIHE?AJH=?
`
`@=OJDAFEE@AFE@AE?M=IJDAB?KIB@EI?KIIEMDAE?D=A*JJE?AE
`
`,EHA?JHB=JE=,HKC+JH2E?OBHJDA9DEJA0KIAIJFFA@>O6DA
`
`2HLE@A?A+AJAHߣI)?DH4A?LAHO+KEJO+AJAHE2=MJK?AJJA=HHA
`
`=>KJJDAIK??AIIB)?DH-,=EL=JELAEJAHLAJE=@HA?LAHOFHCH=JD=J
`
`?A?JILAH@IAF=JEAJIEAAHCA?O@AF=HJAJIMEJDFAAHJFAAHHA?LAHO
`
`IKFFHJ=??H@ECJ=FHAIIHAA=IABH)?DH-,
`
`É4ALAHIECFEE@LAH@IAIMEJD=NAEIAAFECFAFA=ELA>KJMA?=ߣJIJF
`
`JDAHAߝMAD=LAJ?A?JFAFAMEJDJHA=JAJ=BJAH=LAH@IAÉ*JJE?AEI=E@
`
`É)?DH-@EIKIEC=EL=JELA=FFH=?DJD=JߣI>HECECJDA?KEJOJCAJDAHJ
`
`DAFFAFA=??AIIJHA=JAJ=@HA=?DHA?LAHO*OE?HA=IEC=??AIIJALE@A?A
`
`>=IA@JHA=JAJFJEIEAA@E?=JE=IIEIJA@JHA=JAJMA?=I=LAELAI=@
`
`DAFLA4D@A1I=@ߝ=@KH?KJHOߝBH?HEIEIJHA?LAHOÉ
`
`)?DH-,EIF=HJBJDAIJ=JAME@A)?DHB=EOBEJAHLAJE=@HA?LAHO
`
`FHCH=IHK>O6DA2HLE@A?A+AJAH6DAFHCH=>AC=EKAB "MEJD
`
`CH=JBK@ECBHJDA4D@A1I=@,AF=HJAJB*AD=LEH=0A=JD?=HA
`
`,ALAFAJ=,EI=>EEJEAI=@0IFEJ=IJDA4D@A1I=@,AF=HJAJB0A=JD=@
`
`=FHEL=JA@H)?DH-,EIFAH?AJ==CA@=@FAH=JA@>OE@ELE@K=IE
`
`HA?LAHOBHIK>IJ=?AKIA@EIH@AH
`
`É.H=CJEAEJM=IߢJHA=J=@IJHAAJߣߞOKCJJDA-4CAJF=J?DA@KFJDA
`
`OKߣHA>=?KJJDAHAMEJD=KJHA=JA@IK>IJ=?AKIA@EIH@AHMMAD=LA=
`
`?D=?AJ>HA=JD=J?O?A>O?A?JECMEJDE@ELE@K=I=JJDAAJJDAOAA@EJ
`
`IJJA@K?=JA=@A?KH=CAJDAJCAJJHA=JAJÉ)?DH-,?H@E=JH
`
`/AHCAߣ6AI=E@
`
`)??H@ECJJDAFHAIIHAA=IAJDEIOA=H'#E@ELE@K=ID=LAAJMEJD=)?DH-,
`
`2AAH4A?LAHO5FA?E=EIJEAAHCA?O@AF=HJAJI=BJAHIKHLELEC=FEE@
`
`LAH@IAKIJLAH& FAH?AJBJDAIAFAFAD=LAAC=CA@EHA?LAHOIKFFHJI
`
`=BJAH@EI?D=HCABHJDAAAHCA?O@AF=HJAJ=@IJBJDAIKHLELHID=LA
`
`BMA@KFMEJDJDA)?DH4A?LAHO+KEJO+AJAHBHHA?LAHO?=?DEC
`
`JAAFDAHA?LAHOIKFFHJ=@HABAHH=IJA@E?=JE=IIEIJA@JHA=JAJ@AJNH
`
`HA?LAHODKIEC
`
`DJJF MMMHE?AJH=??LAJHO?KHEAHAMI?=AMI?LAJHOFE?AIMEJ?DJ
`
`Opiant Exhibit 2160
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 3
`
`